scholarly journals Chylothorax due to central vein thrombosis treated by venous stenting using a dual approach

Medicine ◽  
2021 ◽  
Vol 100 (49) ◽  
pp. e28100
Author(s):  
Arthur Bouche ◽  
Jean-Francois De Wispelaere ◽  
Françoise Kayser ◽  
Elodie Collinge ◽  
Hadrien Fourneau
Keyword(s):  
Central Vein ◽  
Dual Approach ◽  
Venous Stenting ◽  
Vein Thrombosis

scholarly journals Endovascular mechanical thrombectomy and stenting in a case of central vein thrombosis

2021 ◽  
Vol 14 (2) ◽  
pp. e236508
Author(s):  
Rajesh Vijayvergiya ◽  
Navjyot Kaur ◽  
Saroj K Sahoo ◽  
Ashish Sharma
Keyword(s):  
Mechanical Thrombectomy ◽  
Transluminal Angioplasty ◽  
Brachiocephalic Vein ◽  
Central Vein ◽  
Vein Thrombosis ◽  
Catheter Directed Thrombolysis ◽  
Stage Renal Disease ◽  
End Stage ◽  
Vein Stenosis

Central vein stenosis and thrombosis are frequent in patients on haemodialysis for end-stage renal disease. Its management includes anticoagulation, systemic or catheter-directed thrombolysis, mechanical thrombectomy and percutaneous transluminal angioplasty (PTA). Use of mechanical thrombectomy in central vein thrombosis has been scarcely reported. We hereby report a case of right brachiocephalic vein thrombosis with underlying stenosis, which was successfully treated by mechanical thrombectomy followed by PTA and stenting. The patient had a favourable 10 months of follow-up.

Catheter tip position in central vein thrombosis

1988 ◽  
Vol 12 (6) ◽  
pp. 613-614 ◽  
Author(s):  
A Pithie ◽  
JS Soutar ◽  
CR Pennington
Keyword(s):  
Central Vein ◽  
Vein Thrombosis ◽  
Catheter Tip ◽  
Tip Position

scholarly journals What Does Early Mean? Remarks on Immediate Prosthetic Vascular Access Cannulation for Urgent Hemodialysis

2016 ◽  
Vol 2 (1) ◽  
pp. pocj.5000198
Author(s):  
Marco Franchin ◽  
Gabriele Piffaretti ◽  
Barbara Pasqualetti ◽  
Michele Cavo Dragone ◽  
Francesca Fortin ◽  
...  
Keyword(s):  
Vascular Access ◽  
Blood Gas Analysis ◽  
Gas Analysis ◽  
Maintenance Hemodialysis ◽  
Central Vein ◽  
Real Problem ◽  
Arterial Blood Gas ◽  
Vein Thrombosis ◽  
Arterial Blood ◽  
Vascular Catheters

Management of complicated vascular access. A step-by-step description of a case of hyperkalemia and vascular access failure in a patient receiving maintenance hemodialysis treated for numerous previous stenosis and thrombosis of the native vascular access. The discussion revolves around the following key questions: 1. Basilic vein thrombosis and re-stenosis, what do you think it should be done after this complication? 2. Venous back bleeding was satisfactory; do you think thrombectomy was effective? 3. We thought that central vein stenosis stenting was needed, wasn't it? 4. What do you think about basilic stenosis? The patient had undergone multiple recent basilic angioplasties. Consequently, a surgical intervention could have been definitive. Various surgical options were possible. But first of all, we had to solve a dilemma: The patient had received multiple previous central vascular catheters; our aim was to avoid a new central vascular access placement. At the same time, we required a vascular access for prompt cannulation. Do you think that was a real problem? Do you agree with us, or in the present circumstance, would you have preferred a central venous device? 5. Finally, we decided in favor of creation of a prosthetic vascular access. We chose a graftspecifically designed for early cannulation. Do you agree with us? Do you think early cannulation could cause a worse vascular access outcome? 6. Patient underwent last hemodialysis (HD) 24 hours before surgery. Consequently we trusted that the next HD could be delayed for at least 24 hours. Unfortunately, intraoperative arterial blood gas analysis documented hyperkalemia and acidosis. Our nephrologist suggested HD. In your opinion what does “early” mean?.

scholarly journals Medium-term Results of Venous Stenting for Acute Ilio-femoral Vein Thrombosis

2017 ◽  
Vol 54 (5) ◽  
pp. 664
Author(s):  
J. Silickas ◽  
P. Saha ◽  
A. Smith ◽  
A. Gwozdz ◽  
B. Hunt ◽  
...  
Keyword(s):  
Femoral Vein ◽  
Medium Term ◽  
Venous Stenting ◽  
Vein Thrombosis

scholarly journals Vascular Access for Haemodialysis in Patients with Central Vein Thrombosis

2011 ◽  
Vol 42 (6) ◽  
pp. 842-849 ◽  
Author(s):  
T. Jakimowicz ◽  
Z. Galazka ◽  
T. Grochowiecki ◽  
S. Nazarewski ◽  
J. Szmidt
Keyword(s):  
Vascular Access ◽  
Central Vein ◽  
Vein Thrombosis

scholarly journals Treatment Failure of Venous Stenting With or Without Direct Oral Anticoagulants (DOAC) / Non-Vitamin K Oral Anticoagulants (NOACs) in Patients With Deep Vein Thrombosis (DVT) in Term of the Stent Patency: Protocol for a Systematic Review

2021 ◽  
Author(s):  
Bahram Mohebbi ◽  
Jamal Moosavi ◽  
Behshid Ghadrdoost ◽  
Ayatollah Bayatian ◽  
Hooman Bakhshandeh ◽  
...  
Keyword(s):  
Deep Vein Thrombosis ◽  
Treatment Failure ◽  
Vitamin K ◽  
Patency Rate ◽  
Oral Anticoagulants ◽  
Direct Oral Anticoagulants ◽  
Stent Patency ◽  
Venous Stenting ◽  
Vein Thrombosis ◽  
Deep Vein

Abstract Background: Venous stenting plays a significant role in the treatment of acute deep vein thrombosis (DVT). But the adjuvant anti-coagulant therapy could also help to more successful patency rate. We hope to elucidate the differences in the patency rate of venous stenting with or without direct oral anticoagulants (DOAC) / non-vitamin K oral anticoagulants (NOACs). Methods: Studies that work on the stent patency rate in venous stent with or without DOAC / NOAC will be included. The primary studies (Cohort, case control, case-series or randomized/ non-randomized trials) will be included if the participants / patients have had acute or chronic DVT, with venous stenting (at least one study group or all of study subjects) who have received DOAC / NOAC agents. The stent patency rate should be reported in all of study subjects within a follow-up time, minimum for 1 year. We will perform an electronic search on published or in press articles, which have been published in MEDLINE / PubMed, Embase, the online Cochrane database, CENTRAL and searches of clinical trial registries: clinicalTrials.gov, EU Clinical Trials, ISRCTN registry, WHO network registry for trials. PROSPERO databases will be manually searched for protocols.After screening of the relevant articles, selection and data extraction will be conducted in duplicate and independently. Methodological quality of the selected studies will be assessed using the Newcastle Ottawa Scale (NOS) tool. We will use “Hazard Ratio” (HR) as the optimum Effect Size (ES) in this meta-analysis, otherwise we will use or calculate “Risk Ratio” (RR) or “Odds Ratio” (OR) ES measures as the selected study specific ES. Discussion: In this review, we hope to find the treatment failure/ success rate of venous stenting with or without DOAC / NOAC regards to the stent patency rate and will try to provide insights into the right choice of anti-coagulant therapy.Submitted to PROSPERO (20/9/2021): CRD42021274542

Sign in / Sign up

Export Citation Format

Share Document